Contract SPE2D226D0004
Specgx Llc · Department Of Defense · November 18, 2025
Specgx Llc was awarded a federal contract by Department Of Defense (Defense Logistics Agency) on November 18, 2025 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on November 18, 2025. If all options are exercised, the contract could reach $2.17 million.
Contract details
- PIID
- SPE2D226D0004
- Award type
- Indefinite Delivery / Requirements
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- November 18, 2025
- Latest action
- November 18, 2025
Description
4610128148!
Modification timeline
-
November 18, 2025Base award$0
-
November 18, 2025Base award$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $51 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $91 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $32 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $1.1K |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $22 |
| Cardinal Health, Inc. | Department Of Defense | December 31, 2025 | $23 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract SPE2D226D0004?
Contract SPE2D226D0004 is a federal contract awarded to Specgx Llc by Department Of Defense on November 18, 2025 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract SPE2D226D0004?
Specgx Llc won contract SPE2D226D0004 from Department Of Defense.
How much is contract SPE2D226D0004 worth?
Contract SPE2D226D0004 has obligated $0 to date but carries a potential ceiling of $2.17 million if fully funded and all options are exercised.